Pfizer Loses Patent Over Compound To Treat Breast Cancer
European officials have revoked a Pfizer patent protecting a breast cancer treatment, ruling that the amended invention had extended beyond the original application by deleting a feature....To view the full article, register now.
Already a subscriber? Click here to view full article